{"id":33004,"date":"2026-03-03T09:25:15","date_gmt":"2026-03-03T07:25:15","guid":{"rendered":"https:\/\/vilkaviskiovsb.lt\/?p=33004"},"modified":"2026-03-03T09:25:15","modified_gmt":"2026-03-03T07:25:15","slug":"lietuvoje-pleciamos-pazengusio-prostatos-vezio-gydymo-galimybes","status":"publish","type":"post","link":"https:\/\/vilkaviskiovsb.lt\/en\/2026\/03\/03\/lietuvoje-pleciamos-pazengusio-prostatos-vezio-gydymo-galimybes\/","title":{"rendered":"Lietuvoje ple\u010diamos pa\u017eengusio prostatos v\u0117\u017eio gydymo galimyb\u0117s"},"content":{"rendered":"<div class=\"info-block__wrap clearfix\">\n<p><strong>uo kovo 1 d. pacientams, sergantiems pa\u017eengusiu ar metastazavusiu prostatos v\u0117\u017eiu, atsiveria daugiau gydymo galimybi\u0173 \u2013 \u012f Centralizuotai apmokam\u0173 vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 s\u0105ra\u0161\u0105 \u012ftrauktas ir prad\u0117tas kompensuoti Liutecio (177Lu) vipivotido tetraksetanas.<\/strong><\/p>\n<p>\u201eM\u016bs\u0173 \u0161alyje vyrams prostatos v\u0117\u017eys nustatomas gerokai da\u017eniau nei daugelyje kit\u0173 Europos valstybi\u0173, sergamumo rodikliai vir\u0161ija pasaulio vidurk\u012f, tod\u0117l reikia kuo platesnio spektro gydymo priemoni\u0173, \u00a0\u2013 sako sveikatos apsaugos viceministras Daniel Naumovas. \u2013 Atlikti klinikiniai tyrimai parod\u0117, kad gydymas \u0161iuo vaistu prailgina pacient\u0173, kuriems liga progresavo po kit\u0173 gydymo b\u016bd\u0173, i\u0161gyvenamum\u0105, l\u0117tina ligos progresavim\u0105, ma\u017eina naviko aktyvum\u0105, padeda suma\u017einti skausm\u0105 ir kitus ligos simptomus, o tai gali pagerinti gyvenimo kokyb\u0119.\u201c<\/p>\n<p>Gydymas Liutecio (177Lu) vipivotido tetraksetanu gali b\u016bti skiriamas, vaist\u0105 derinant su androgen\u0173 tr\u016bkumo terapija (ADT) su arba be androgen\u0173 receptori\u0173 (AR) inhibitoriais, suaugusiems pacientams, sergantiems progresuojan\u010diu prostatos specifiniam membranos antigenui teigiamu metastaziniu kastracijai atspariu prostatos v\u0117\u017eiu (TLK-10-AM kodas C61), jei jiems anks\u010diau buvo skirtas gydymas AR inhibitoriais ir chemoterapija taksan\u0173 pagrindu.<\/p>\n<p>Europos S\u0105jungos statistika rodo, kad Lietuva i\u0161lieka tarp pirmaujan\u010di\u0173 \u0161ali\u0173 pagal sergamum\u0105 prostatos v\u0117\u017eiu. Nacionalinio v\u0117\u017eio instituto duomenimis, prostatos v\u0117\u017eys kasmet diagnozuojamas apie 2 t\u016bkst. vyr\u0173, ir net 500 vyr\u0173 \u00a0&#8211; tai tampa mirties prie\u017eastimi.<\/p>\n<p>Sveikatos apsaugos ministerija primena, kad Prie\u0161in\u0117s liaukos v\u0117\u017eio ankstyvosios diagnostikos programa yra apmokama Privalomojo sveikatos draudimo fondo l\u0117\u0161omis, tod\u0117l vyrai nemokamai gali pasir\u016bpinti savo sveikata. Did\u017eioji dalis pirmose ligos stadijose diagnozuojam\u0173 atvej\u0173 yra nustatomi dalyvaujantiems \u0161ioje profilaktin\u0117je programoje, ir tik apie 3,2 proc. naujai diagnozuot\u0173 ligos atvej\u0173 yra IV stadijos, t. y. nustatomas lokaliai i\u0161plit\u0119s arba metastazav\u0119s v\u0117\u017eys.<\/p>\n<\/div>\n<div class=\"info-block__wrap clearfix\">\n<p>SAM informacija<\/p>\n<p>Atnaujinimo data: 2026-03-02<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>uo kovo 1 d. pacientams, sergantiems pa\u017eengusiu ar metastazavusiu prostatos v\u0117\u017eiu, atsiveria daugiau gydymo galimybi\u0173 \u2013 \u012f Centralizuotai apmokam\u0173 vaistini\u0173 preparat\u0173 ir medicinos pagalbos priemoni\u0173 s\u0105ra\u0161\u0105 \u012ftrauktas ir prad\u0117tas kompensuoti Liutecio (177Lu) vipivotido tetraksetanas. \u201eM\u016bs\u0173 \u0161alyje vyrams prostatos v\u0117\u017eys nustatomas gerokai da\u017eniau nei daugelyje kit\u0173 Europos valstybi\u0173, sergamumo rodikliai vir\u0161ija pasaulio vidurk\u012f, tod\u0117l reikia kuo&hellip;<\/p>","protected":false},"author":3,"featured_media":33005,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[6],"tags":[],"class_list":["post-33004","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-naujienos","category-6","description-off"],"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p7kWFe-8Ak","jetpack_featured_media_url":"https:\/\/vilkaviskiovsb.lt\/wp-content\/uploads\/2026\/03\/1.jpg","post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/33004","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/comments?post=33004"}],"version-history":[{"count":1,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/33004\/revisions"}],"predecessor-version":[{"id":33006,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/posts\/33004\/revisions\/33006"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/media\/33005"}],"wp:attachment":[{"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/media?parent=33004"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/categories?post=33004"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vilkaviskiovsb.lt\/en\/wp-json\/wp\/v2\/tags?post=33004"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}